Ticker XBRANEListed on Nasdaq Stockholm

Xbrane Biopharma AB

ISIN SE0007789409Filings at the FI

At a glance

Most recent filing on January 20, 2025 — an open-market purchase by Karl Martin Erik Åmark on Jan 17, 2025.

Over the past 12 months: 0 open-market purchases and 0 open-market sales.

We hold 156 visible filings, going back to October 24, 2016.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

5 of 156 shown